About this degree
The content includes a focused set of core modules specialising in all aspects of personalised medicine and clinical translation.
Optional modules allow you to explore the applications and scope of personalised medicine, including applications, entrepreneurship and pharmacometrics. You are given opportunities to develop analytical skills during the programme before undertaking your independent research project.
Who this course is for
This programme is designed for scientists (or those with a strong interest in the field) wishing to pursue a career in the rapidly developing field of personalised medicine. It is also suitable for medical practitioners, pharmacists and those with an interest in ethics and law who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
What this course will give you
The next generation of scientists and healthcare workers must be trained to deliver this change in medicine and research landscapes. Our programme offers you access to cutting-edge research taught by leading academics and clinicians in personalised medicine from UCL and Great Ormond Street Hospital, as well as a range of project choices from computational biology to drug development and clinical translation. The programme prepares you to become a scientist or researcher in academia or industry, as well as for progression to a higher research degree.
UCL's cross-disciplinary research into personalised medicine harnesses the breadth and depth of expertise across the institution and benefits from close links with our partner hospitals to support the delivery of innovative patient-targeted medicines and therapies. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers within UCL's Great Ormond Street Institute of Child Health (GOS ICH), Division of Infection & Immunity, Institute of Ophthalmology, the EGA Institute for Women's Health, Institute of Genetics and the Cancer Institute, as well as University College London Hospital (UCLH) and UCL Research and Innovation.
